tiprankstipranks
Advertisement
Advertisement

XERS Stock Latest News

Xeris Biopharma: Buy Rating Reiterated on Strong Recorlev Momentum and Raised 2026 Outlook; $10 Price Target Maintained
RatingsXeris Biopharma: Buy Rating Reiterated on Strong Recorlev Momentum and Raised 2026 Outlook; $10 Price Target Maintained
8d ago
XERS
Xeris Pharmaceuticals’ Earnings Call Highlights Growth Momentum
PremiumCompany Announcements
Xeris Pharmaceuticals’ Earnings Call Highlights Growth Momentum
8d ago
XERS
Xeris Biopharma reports Q2 EPS (18c), consensus $0.00
PremiumThe Fly
Xeris Biopharma reports Q2 EPS (18c), consensus $0.00
9d ago
XERS
Xeris Biopharma tightens FY26 revnue view $385M-$390M, consensus $385.94M
PremiumThe Fly
Xeris Biopharma tightens FY26 revnue view $385M-$390M, consensus $385.94M
9d ago
XERS
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
PremiumCompany Announcements
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
28d ago
8K
XERS
Xeris Pharmaceuticals appoints new director and board chair
PremiumCompany AnnouncementsXeris Pharmaceuticals appoints new director and board chair
2M ago
8K
XERS
Xeris Biopharma appoints CEO John Shannon as chair of the board
Premium
The Fly
Xeris Biopharma appoints CEO John Shannon as chair of the board
2M ago
XERS
Xeris Biopharma announces notice of allowance from USPTO for Keveyis patent
Premium
The Fly
Xeris Biopharma announces notice of allowance from USPTO for Keveyis patent
2M ago
XERS
Xeris Biopharma Announces Debt Reduction via Note Exchanges
PremiumCompany Announcements
Xeris Biopharma Announces Debt Reduction via Note Exchanges
2M ago
8K
XERS
Xeris Biopharma announces private exchange of convertible notes
PremiumThe Fly
Xeris Biopharma announces private exchange of convertible notes
2M ago
XERS
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
PremiumCompany Announcements
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
2M ago
8K
XERS
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
PremiumCompany Announcements
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
3M ago
XERS
Xeris Biopharma reports Q1 EPS 1c, consensus 0c
PremiumThe FlyXeris Biopharma reports Q1 EPS 1c, consensus 0c
3M ago
XERS
Xeris Biopharma Announces Board Transition as Director Retires
Premium
Company Announcements
Xeris Biopharma Announces Board Transition as Director Retires
4M ago
8K
XERS
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
Premium
Company Announcements
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
5M ago
XERS
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
PremiumTipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
6M ago
NSRX
XERS
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
PremiumThe Fly
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
6M ago
XERS
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
PremiumThe Fly
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
6M ago
XERS
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
6M ago
XERS
Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
PremiumThe FlyXeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
6M ago
XERS
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
Premium
Market News
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
6M ago
COF
VIR
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
Premium
Ratings
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
7M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >